No Data
No Data
Alnylam Pharmaceuticals(ALNY.US) Director Sells US$3.22 Million in Common Stock
$Alnylam Pharmaceuticals(ALNY.US)$ Director SCHULMAN AMY W sold 21,700 shares of common stock on May 29, 2024 at an average price of $148.6 for a total value of $3.22 million.Source: Announcement What
Form 144 | Alnylam Pharmaceuticals(ALNY.US) Director Proposes to Sell 3.25 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 29, $Alnylam Pharmaceuticals(ALNY.US)$ Director SCHULMAN AMY W intends to sell 21,700 shares of its common stock on May 29, with a total market value of approximately $3.25
Global Juvenile Macular Degeneration Clinical Trials Review 2024, Featuring Lin Bioscience, Nanoscope Therapeutics, Alnylam Pharmaceuticals, Biophytis, Kubota Pharmaceutical and Nucleus Network
Investors in Alnylam Pharmaceuticals (NASDAQ:ALNY) Have Seen Solid Returns of 119% Over the Past Five Years
When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really flourishing, you can make more than 100%. Long term Alnylam Pharmaceuticals, In
Viking, CRISPR, Intellia Among Potential M&A Targets: Wells Fargo
(ALNY) - Analyzing Alnylam Pharmaceuticals's Short Interest
Alnylam Pharmaceuticals's (NYSE:ALNY) short percent of float has risen 4.82% since its last report. The company recently reported that it has 2.63 million shares sold short, which is 2.39% of all regu
No Data
diamonds : Excuse me, can shares held still be valid after ENDPQ's restructuring?